IDXX
Price
$514.61
Change
-$4.10 (-0.79%)
Updated
Jul 18, 04:59 PM (EDT)
Capitalization
44.84B
17 days until earnings call
ISRG
Price
$516.22
Change
+$3.58 (+0.70%)
Updated
Jul 18, 04:27 PM (EDT)
Capitalization
141.46B
4 days until earnings call
Interact to see
Advertisement

IDXX vs ISRG

Header iconIDXX vs ISRG Comparison
Open Charts IDXX vs ISRGBanner chart's image
IDEXX Laboratories
Price$514.61
Change-$4.10 (-0.79%)
Volume$1.11K
Capitalization44.84B
Intuitive Surgical
Price$516.22
Change+$3.58 (+0.70%)
Volume$874
Capitalization141.46B
IDXX vs ISRG Comparison Chart in %
Loading...
IDXX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ISRG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDXX vs. ISRG commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDXX is a Hold and ISRG is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 18, 2025
Stock price -- (IDXX: $518.71 vs. ISRG: $516.16)
Brand notoriety: IDXX: Not notable vs. ISRG: Notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: IDXX: 78% vs. ISRG: 128%
Market capitalization -- IDXX: $44.84B vs. ISRG: $141.46B
IDXX [@Medical Specialties] is valued at $44.84B. ISRG’s [@Medical Specialties] market capitalization is $141.46B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDXX’s FA Score shows that 1 FA rating(s) are green whileISRG’s FA Score has 1 green FA rating(s).

  • IDXX’s FA Score: 1 green, 4 red.
  • ISRG’s FA Score: 1 green, 4 red.
According to our system of comparison, IDXX is a better buy in the long-term than ISRG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDXX’s TA Score shows that 4 TA indicator(s) are bullish while ISRG’s TA Score has 4 bullish TA indicator(s).

  • IDXX’s TA Score: 4 bullish, 5 bearish.
  • ISRG’s TA Score: 4 bullish, 7 bearish.
According to our system of comparison, IDXX is a better buy in the short-term than ISRG.

Price Growth

IDXX (@Medical Specialties) experienced а -4.14% price change this week, while ISRG (@Medical Specialties) price change was -1.88% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.65%. For the same industry, the average monthly price growth was +2.06%, and the average quarterly price growth was -2.13%.

Reported Earning Dates

IDXX is expected to report earnings on Nov 04, 2025.

ISRG is expected to report earnings on Oct 16, 2025.

Industries' Descriptions

@Medical Specialties (-0.65% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ISRG($141B) has a higher market cap than IDXX($44.8B). ISRG has higher P/E ratio than IDXX: ISRG (78.50) vs IDXX (52.87). IDXX YTD gains are higher at: 25.462 vs. ISRG (-1.111). ISRG has higher annual earnings (EBITDA): 2.19B vs. IDXX (1.22B). ISRG has more cash in the bank: 5.22B vs. IDXX (454M). ISRG has higher revenues than IDXX: ISRG (7.12B) vs IDXX (3.66B).
IDXXISRGIDXX / ISRG
Capitalization44.8B141B32%
EBITDA1.22B2.19B56%
Gain YTD25.462-1.111-2,291%
P/E Ratio52.8778.5067%
Revenue3.66B7.12B51%
Total Cash454M5.22B9%
Total Debt1.07BN/A-
FUNDAMENTALS RATINGS
IDXX vs ISRG: Fundamental Ratings
IDXX
ISRG
OUTLOOK RATING
1..100
7068
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
88
Overvalued
PROFIT vs RISK RATING
1..100
6123
SMR RATING
1..100
1753
PRICE GROWTH RATING
1..100
4656
P/E GROWTH RATING
1..100
5254
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IDXX's Valuation (87) in the Medical Specialties industry is in the same range as ISRG (88). This means that IDXX’s stock grew similarly to ISRG’s over the last 12 months.

ISRG's Profit vs Risk Rating (23) in the Medical Specialties industry is somewhat better than the same rating for IDXX (61). This means that ISRG’s stock grew somewhat faster than IDXX’s over the last 12 months.

IDXX's SMR Rating (17) in the Medical Specialties industry is somewhat better than the same rating for ISRG (53). This means that IDXX’s stock grew somewhat faster than ISRG’s over the last 12 months.

IDXX's Price Growth Rating (46) in the Medical Specialties industry is in the same range as ISRG (56). This means that IDXX’s stock grew similarly to ISRG’s over the last 12 months.

IDXX's P/E Growth Rating (52) in the Medical Specialties industry is in the same range as ISRG (54). This means that IDXX’s stock grew similarly to ISRG’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IDXXISRG
RSI
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
67%
Momentum
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 2 days ago
58%
MACD
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
62%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
59%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
67%
Advances
ODDS (%)
Bullish Trend 9 days ago
68%
Bullish Trend 2 days ago
72%
Declines
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 8 days ago
58%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
53%
Aroon
ODDS (%)
Bullish Trend 2 days ago
61%
Bearish Trend 2 days ago
54%
View a ticker or compare two or three
Interact to see
Advertisement
IDXX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ISRG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TSMY16.730.34
+2.07%
YieldMax TSM Option Inc Strat ETF
WEA10.770.01
+0.09%
Western Asset Premier
TYLD25.31-0.01
-0.02%
Cambria Tactical Yield ETF
EMLC25.11-0.03
-0.12%
VanEck JPMorgan EMLcl Ccy Bd ETF
ETO27.25-0.05
-0.18%
Eaton Vance Tax-Advantaged Global Div Oppor Fund